Supplemental Guarantor Information

12 Months Ended

Dec. 31, 2011

Supplemental Guarantor Information [Abstract]

Supplemental Guarantor Information

Note 25:     Supplemental Guarantor Information

As of December 31, 2011, Belden Inc. (the Issuer) has outstanding $550.0 million aggregate principal amount of senior subordinated notes. The notes rank equal in right of payment with any of our future senior subordinated debt. The notes are subordinated to all of our senior debt and the senior debt of our subsidiary guarantors, including our Senior Secured Facility. Belden Inc. and certain of its subsidiaries have fully and unconditionally guaranteed the notes on a joint and several basis. In addition, effective April 25, 2011, in connection with the refinancing of our Senior Secured Facility, the guarantor subsidiaries of the notes have been revised. The financial position, results of operations, and cash flows of the guarantor subsidiaries are not material and are combined with the Issuer in the following consolidating financial information. All subsidiary guarantors are 100% owned by the Issuer.

The following consolidating financial information presents information about the Issuer and non-guarantor subsidiaries. Investments in subsidiaries are accounted for on the equity basis. Intercompany transactions are eliminated.

Supplemental Condensed Consolidating Balance Sheets

	December 31, 2011
	Issuer			Non- Guarantor Subsidiaries		Eliminations			Total
	(In thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	92,586		$	290,130	$	—		$	382,716
Receivables, net		117,920			181,150		—			299,070
Inventories, net		125,168			76,975		—			202,143
Deferred income taxes		15,737			3,923		—			19,660
Other current assets		10,121			11,711		—			21,832
Total current assets		361,532			563,889		—			925,421
Property, plant and equipment, less accumulated depreciation		132,909			154,024		—			286,933
Goodwill		242,808			105,224		—			348,032
Intangible assets, less accumulated amortization		77,455			74,228		—			151,683
Deferred income taxes		(1,829	)		14,048		—			12,219
Other long-lived assets		13,666			50,166		—			63,832
Investment in subsidiaries		1,306,843			—		(1,306,843	)		—
	$	2,133,384		$	961,579	$	(1,306,843	)	$	1,788,120
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	94,647		$	132,924	$	—		$	227,571
Accrued liabilities		73,579			80,416		—			153,995
Total current liabilities		168,226			213,340		—			381,566
Long-term debt		550,926			—		—			550,926
Postretirement benefits		42,855			88,382		—			131,237
Other long-term liabilities		23,628			6,214		—			29,842
Intercompany accounts		(33,617	)		33,617		—			—
Total stockholders’ equity		1,381,366			620,026		(1,306,843	)		694,549
	$	2,133,384		$	961,579	$	(1,306,843	)	$	1,788,120

	December 31, 2010
	Issuer			Non- Guarantor Subsidiaries		Eliminations			Total
				(In thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	173,699		$	184,954	$	—		$	358,653
Receivables, net		117,303			180,963		—			298,266
Inventories, net		109,127			66,532		—			175,659
Deferred income taxes		5,590			3,883		—			9,473
Other current assets		10,199			8,605		—			18,804
Total current assets		415,918			444,937		—			860,855
Property, plant and equipment, less accumulated depreciation		120,857			158,009		—			278,866
Goodwill		258,094			64,462		—			322,556
Intangible assets, less accumulated amortization		93,695			50,125		—			143,820
Deferred income taxes		9,342			18,223		—			27,565
Other long-lived assets		12,771			50,051		—			62,822
Investment in subsidiaries		1,227,959			—		(1,227,959	)		—
	$	2,138,636		$	785,807	$	(1,227,959	)	$	1,696,484
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	92,996		$	119,088	$	—		$	212,084
Accrued liabilities		78,013			67,827		—			145,840
Total current liabilities		171,009			186,915		—			357,924
Long-term debt		551,155			—		—			551,155
Postretirement benefits		27,949			84,477		—			112,426
Other long-term liabilities		30,047			6,417		—			36,464
Intercompany accounts		(249,051	)		249,051		—			—
Total stockholders’ equity		1,607,527			258,947		(1,227,959	)		638,515
	$	2,138,636		$	785,807	$	(1,227,959	)	$	1,696,484

Supplemental Condensed Consolidating Statements of Operations

	Year Ended December 31, 2011
	Issuer			Non- Guarantor Subsidiaries			Eliminations			Total
	(In thousands)
Revenues	$	1,056,363		$	1,140,060		$	(214,470	)	$	1,981,953
Cost of sales		(789,599	)		(835,005	)		214,470			(1,410,134	)
Gross profit		266,764			305,055			—			571,819
Selling, general and administrative expenses		(177,903	)		(148,047	)		—			(325,950	)
Research and development		(12,194	)		(43,517	)		—			(55,711	)
Amortization of intangibles		(4,851	)		(8,921	)		—			(13,772	)
Income from equity method investment		—			13,169			—			13,169
Asset impairment		(2,549	)		—			—			(2,549	)
Operating income		69,267			117,739			—			187,006
Interest expense		(47,011	)		(1,115	)		—			(48,126	)
Interest income		94			917			—			1,011
Intercompany income (expense)		13,709			(13,709	)		—			—
Income (loss) from equity investment in subsidiaries		81,750			—			(81,750	)		—
Income (loss) from continuing operations before taxes		117,809			103,832			(81,750	)		139,891
Income tax benefit (expense)		(2,556	)		(22,082	)		—			(24,638	)
Income (loss) from continuing operations		115,253			81,750			(81,750	)		115,253
Loss from discontinued operations, net of tax		(908	)		—			—			(908	)
Net income (loss)	$	114,345		$	81,750		$	(81,750	)	$	114,345

	Year Ended December 31, 2010
	Issuer			Non- Guarantor Subsidiaries			Eliminations			Total
	(In thousands)
Revenues	$	874,866		$	916,504		$	(174,280	)	$	1,617,090
Cost of sales		(616,401	)		(707,675	)		174,280			(1,149,796	)
Gross profit		258,465			208,829			—			467,294
Selling, general and administrative expenses		(161,675	)		(118,002	)		—			(279,677	)
Research and development		(11,915	)		(30,690	)		—			(42,605	)
Amortization of intangibles		(3,523	)		(7,666	)		—			(11,189	)
Income from equity method investment		—			11,940			—			11,940
Asset impairment		(10,790	)		(5,784	)		—			(16,574	)
Operating income		70,562			58,627			—			129,189
Interest expense		(48,829	)		(997	)		—			(49,826	)
Interest income		159			1,025			—			1,184
Other income		—			1,465			—			1,465
Intercompany income (expense)		(7,876	)		7,876			—			—
Income (loss) from equity investment in subsidiaries		50,194			—			(50,194	)		—
Income (loss) from continuing operations before taxes		64,210			67,996			(50,194	)		82,012
Income tax benefit (expense)		5,088			(17,802	)		—			(12,714	)
Income (loss) from continuing operations		69,298			50,194			(50,194	)		69,298
Loss from discontinued operations, net of tax		(5,686	)		—			—			(5,686	)
Gain from disposal of discontinued operations, net of tax		44,847			—			—			44,847
Net income (loss)	$	108,459		$	50,194		$	(50,194	)	$	108,459

	Year Ended December 31, 2009
	Issuer			Non- Guarantor Subsidiaries			Eliminations			Total
	(In thousands)
Revenues	$	681,997		$	835,322		$	(155,303	)	$	1,362,016
Cost of sales		(480,650	)		(648,984	)		155,303			(974,331	)
Gross profit		201,347			186,338			—			387,685
Selling, general and administrative expenses		(124,510	)		(137,963	)		—			(262,473	)
Research and development		(9,623	)		(30,818	)		—			(40,441	)
Amortization of intangibles		(2,008	)		(7,863	)		—			(9,871	)
Income from equity method investment		—			6,405						6,405
Asset impairment		(4,343	)		(23,408	)		—			(27,751	)
Loss on sale of assets		—			(17,184	)		—			(17,184	)
Operating income (loss)		60,863			(24,493	)		—			36,370
Interest expense		(41,488	)		(474	)		—			(41,962	)
Interest income		254			789			—			1,043
Other expense		(1,541	)		—			—			(1,541	)
Intercompany income (expense)		88			(88	)		—			—
Income (loss) from equity investment in subsidiaries		(21,059	)		—			21,059			—
Income (loss) from continuing operations before taxes		(2,883	)		(24,266	)		21,059			(6,090	)
Income tax benefit (expense)		(4,382	)		3,207			—			(1,175	)
Income (loss) from continuing operations		(7,265	)		(21,059	)		21,059			(7,265	)
Loss from discontinued operations, net of tax		(17,636	)		—			—			(17,636	)
Net income (loss)	$	(24,901	)	$	(21,059	)	$	21,059		$	(24,901	)

Supplemental Condensed Consolidating Cash Flow Statements

	Year Ended December 31, 2011
	Issuer			Non- Guarantor Subsidiaries			Total
	(In thousands)
Net cash provided by operating activities	$	60,648		$	123,915		$	184,563
Cash flows from investing activities:
Cash used to acquire business, net of cash acquired		(60,519	)		—			(60,519	)
Capital expenditures		(26,061	)		(13,992	)		(40,053	)
Proceeds from disposal of businesses and tangible assets		1,136			77			1,213
Net cash used for investing activities		(85,444	)		(13,915	)		(99,359	)
Cash flows from financing activities:
Payments under share repurchase program		(50,000	)		—			(50,000	)
Cash dividends paid		(9,410	)		—			(9,410	)
Debt issuance costs		(3,296	)		—			(3,296	)
Tax benefit related to share-based compensation		1,790			—			1,790
Proceeds from exercises of stock options		4,599			—			4,599
Net cash used for financing activities		(56,317	)		—			(56,317	)
Effect of currency exchange rate changes on cash and cash equivalents		—			(4,824	)		(4,824	)
Increase (decrease) in cash and cash equivalents		(81,113	)		105,176			24,063
Cash and cash equivalents, beginning of period		173,699			184,954			358,653
Cash and cash equivalents, end of period	$	92,586		$	290,130		$	382,716

	Year Ended December 31, 2010
	Issuer			Non- Guarantor Subsidiaries			Total
	(In thousands)
Net cash provided by operating activities	$	109,850		$	1,699		$	111,549
Cash flows from investing activities:
Cash used to acquire business, net of cash acquired		(119,110	)		—			(119,110	)
Proceeds from disposal of businesses and tangible assets		138,934			18			138,952
Capital expenditures		(16,056	)		(12,138	)		(28,194	)
Net cash provided by (used for) investing activities		3,768			(12,120	)		(8,352	)
Cash flows from financing activities:
Payments under borrowing arrangements		(46,268	)		—			(46,268	)
Cash dividends paid		(9,412	)		—			(9,412	)
Tax deficiency related to share-based compensation		(110	)		—			(110	)
Proceeds from exercises of stock options		3,158			—			3,158
Intercompany capital contributions and dividends		49,641			(49,641	)		—
Cash received upon termination of derivative instruments		4,217			—			4,217
Net cash provided by (used for) financing activities		1,226			(49,641	)		(48,415	)
Effect of currency exchange rate changes on cash and cash equivalents		—			(5,008	)		(5,008	)
Increase (decrease) in cash and cash equivalents		114,844			(65,070	)		49,774
Cash and cash equivalents, beginning of period		58,855			250,024			308,879
Cash and cash equivalents, end of period	$	173,699		$	184,954		$	358,653

	Year Ended December 31, 2009
	Issuer			Non- Guarantor Subsidiaries			Total
	(In thousands)
Net cash provided by operating activities	$	63,176		$	88,634		$	151,810
Cash flows from investing activities:
Capital expenditures		(20,725	)		(19,652	)		(40,377	)
Cash used to acquire businesses, net of cash acquired		(20,110	)		(593	)		(20,703	)
Proceeds from disposal of businesses and tangible assets		910			1,121			2,031
Net cash used for investing activities		(39,925	)		(19,124	)		(59,049	)
Cash flows from financing activities:
Borrowings under credit arrangements		193,732			—			193,732
Payments under borrowing arrangements		(193,732	)		—			(193,732	)
Debt issuance costs paid		(11,810	)					(11,810	)
Cash dividends paid		(9,373	)		—			(9,373	)
Tax deficiency related to share-based payments		(1,564	)		—			(1,564	)
Proceeds from exercises of stock options		699			—			699
Net cash used for financing activities		(22,048	)		—			(22,048	)
Effect of currency exchange rate changes on cash and cash equivalents		—			10,753			10,753
Increase in cash and cash equivalents		1,203			80,263			81,466
Cash and cash equivalents, beginning of year		57,652			169,761			227,413
Cash and cash equivalents, end of year	$	58,855		$	250,024		$	308,879